Although rare in women of childbearing age, renal cell carcinoma is the commonest renal neoplasm occurring in pregnancy 1 and is potentially curable with prompt diagnosis and treatment. However, the symptoms can mimic more common disorders such as urinary tract infection.
CASE HISTORIES Case 1
A woman aged 28, gravida 2, para 1, was referred for evaluation of a right renal mass at fourteen weeks' gestation. She had no previous history of hypertension, renal disease, or pre-eclampsia. The mass had been detected after onset of right¯ank and loin pain, and hypertension of 150/90 mmHg, at twelve weeks' gestation. Urinalysis, urea, electrolytes and creatinine were normal. Urine cytology was negative. Renal ultrasonography revealed a 1066.567.4 cm solid mass with heterogeneous echotexture arising from the lower pole of the right kidney.
After extensive counselling and consultation with obstetric staff, it was decided that she should undergo a right radical nephrectomy, which was performed at seventeen weeks' gestation. She received standard perioperative antibiotic prophylaxis, and in addition lowmolecular-weight heparin and a twenty-four-hour infusion of the tocolytic b-agonist ritodrine. Postoperatively she recovered without incident and was discharged on day seven. The remainder of the pregnancy was uneventful. She was induced at forty weeks' gestation for worsening hypertension, and gave birth to a healthy boy weighing 2.5 kg.
On histopathological examination the surgical specimen contained a grade II clear-cell renal carcinoma, with a maximum diameter of 9 cm. Pathological staging was T2 N0 Mx. The patient remains well with no evidence of recurrence at twelve months' follow-up.
Case 2
A woman of 24, gravida 1, para 0, was referred at twentythree weeks' gestation for assessment of episodic haematuria. She had no relevant medical history. Microscopic haematuria had been detected at her antenatal booking visit at twelve weeks' gestation. Microbiological culture was negative at that time and no further evaluation was performed until twenty-four weeks' gestation when she was referred with right loin pain and episodic frank haematuria. A full blood count and urea, creatinine and electrolytes were normal. Renal ultrasonography revealed a well-de®ned 5 cm solid mass arising from the medial aspect of the mid to lower part of the right kidney. An ultrasoundguided biopsy was taken but the cytopathological appearances did not allow certain differentiation between an oncocytoma and a well-differentiated renal cell carcinoma. After further obstetric consultation, she underwent a right radical nephrectomy at twenty-®ve weeks' gestation. Preoperatively she received prophylactic corticosteroids to reduce the likelihood of neonatal respiratory distress syndrome, should she deliver before term. She also received indometacin as a tocolytic agent. Initial postoperative recovery was uneventful; however, she did experience symptoms suggestive of preterm labour on the sixth postoperative day and was treated with an infusion of ritodrine for twenty-four hours. Her symptoms settled and she was discharged. She subsequently underwent induction of labour at forty weeks' gestation and a 3.3 kg boy was delivered by emergency caesarean section for fetal distress.
Histopathological examination revealed a grade I renal cell carcinoma. There was no invasion of the renal capsule. There has been no evidence of recurrence at 5 years' follow-up.
COMMENT
Although renal cell carcinoma accounts for 3% of all adult malignancies, it is rare in women of childbearing age. To date there are reports of about ®fty cases diagnosed during pregnancy: it is the most common renal neoplasm reported in pregnancy, accounting for half of all primary tumours 1 . Sex and age matched data do not exist to allow comparison of the relative proportion occurring outside of pregnancy, although in general terms there is no evidence of an increased incidence of malignant neoplasms in pregnancy 2 .
Pregnancy and cancer are the only two biological conditions in which antigenic tissue is tolerated by a normally functioning immune system. However, there have been no demonstrable immunode®ciencies in pregnancy to antigens carried by tumour cells 3 . Furthermore, in most cases the biological behaviour of malignancy is not in¯uenced by pregnancy, with the possible exception of a small subgroup of hormonally sensitive malignant melanomas 4 . With breast cancer, although it seems to present at more advanced stages in pregnancy, the prognosis of each stage is similar to that in non-pregnant women 5 .
In 1986, Walker and Knight 1 reviewed the presentation of renal cell carcinoma during pregnancy and found that the commonest presenting symptoms of such tumours were a palpable mass (88%) and pain (50%). Haematuria and hypertension accounted for 47% and 18% of cases, respectively. A subsequent review has suggested that there has been a change in the presentation of renal cell carcinoma in pregnant women, with diagnosis now more frequently made incidentally during ultrasound examination performed for other reasons 6 . In addition, urinary tract symptoms are experienced by many pregnant women and are often due to non-neoplastic causes, such as calculi or urinary tract infection. Similarly, hypertension, especially during the third trimester, is often induced by pregnancy and related to pre-eclampsia. This means that renal cell carcinoma may not be considered as a potential cause for such symptoms, thus leading to delay in diagnosis and treatment.
Diagnostic evaluation of the pregnant patient with possible renal carcinoma requires special consideration of non-invasive techniques and as little radiation exposure as possible to mother and fetus. As a ®rst step, urine should be sent for cytological analysis. In non-pregnant patients intravenous pyelography (IVP) and abdominal CT are the modalities frequently employed in the evaluation of renal tumours, but there is no proven safe threshold dose of radiation exposure to the fetus 7 . Abdominal ultrasound along with magnetic resonance imaging (MRI) can adequately identify, differentiate between, and stage solid renal masses in most cases, and with their avoidance of radiation exposure to the fetus these are the investigations of choice.
Indeed, ultrasound has a similar sensitivity (85%) to that of IVP and CT for renal masses greater than 3 cm, and is much more sensitive than IVP for renal masses between 2 and 3 cm (82% v 52%) 8 . Renal radionucleotide scans, being associated with less radiation exposure than routine X-ray ®lms, have been used to determine function of the contralateral kidney and intrinsic activity. They do, however, pose additional risks to the fetus from the passage of radiopharmaceuticals and contrast agents across the placenta. As an alternative, doppler assessment of the contralateral kidney may be employed.
There are several issues to consider when treating a pregnant woman with a solid renal mass that is suspicious for malignancy. First, the clinician's primary responsibility is to the mother, though management must take into account her wishes regarding the welfare of the fetus. Secondly, such cases should be managed in a multidisciplinary setting involving urologists, obstetricians, neonatologists, radiologists, histopathologists and oncologists. Thirdly, the standard surgical treatment of most stages of renal cell carcinoma is a radical nephrectomy, involving the en bloc removal of the entire kidney and perinephric fat within Gerota's fascia. This has been performed via both transperitoneal and extraperitoneal approaches. The small numbers of reported cases of renal cell carcinoma in pregnancy allow few conclusions to be drawn regarding the outcomes of each. However, avoidance of disruption of the peritoneal cavity in the extraperitoneal approach may theoretically be associated with less uterine irritation and in turn fewer obstetric complications, including preterm labour.
The timing of surgery is guided by the biological behaviour of such tumours and neonatal survival rates for different gestations. The doubling time of a renal cell carcinoma is estimated at 300 days 9 . Certain considerations should be made when embarking on surgery in pregnant women. Non-obstetric surgery is performed in approximately 1 in 500 pregnancies 10 . When surgery is performed during the ®rst trimester there is an increased risk of preterm labour with its associated problems of fetal prematurity. However, with the improvements in neonatal care, fetal survival rates continue to increase and although actual ®gures vary between different neonatal units, neonatal survival rates of over 90% can be expected beyond twenty-eight weeks' gestation. Therefore, it is recommended that surgery should not be delayed in the ®rst and third trimesters. However, if a mass is diagnosed in the second trimester then it is reasonable to wait until fetal viability before proceeding to surgery. A complicating factor in the management of dementia with Lewy bodies (DLB) is the profound sensitivity of patients to antipsychotic treatment 1 , which in turn may initiate or enhance movement disorders. Florid psychotic symptoms may, however, develop before DLB can be diagnosed.
CASE HISTORY
A woman aged 60 came to psychiatric attention for the ®rst time when referred for advice on depression and morbid jealousy which had existed for many months. She had also experienced hallucinations and misidenti®cation delusions. Initially she was treated with an antipsychotic (tri¯uoper-azine 2 mg twice daily) and an antidepressant (amitriptyline 125 mg daily). Over the next few months there were repeated episodes of falling and syncope with¯uctuating confusion, and a drop in her Mini-Mental State examination score indicated rapid deterioration in her cognitive abilities. Therefore, tri¯uoperazine was replaced with the newer atypical antipsychotic olanzapine, 5 mg daily. The results of all investigations were normal except for a CT scan of the brain, which showed moderate cerebral atrophy. Dementia with Lewy bodies was diagnosed. Although the depressive and psychotic symptoms had been improved by treatment, this bene®t was overshadowed a few months later by the development of persistent involuntary bilateral blinking resulting from repetitive and prolonged contractions of the orbicularis oculi muscles (blepharospasm). Soon afterwards she began to experience an oromandibular dystonia characterized by spasms of the lower face muscles, especially those surrounding the mouth. The choreoathetotic movements seen in tardive dyskinesia were absent, and there was no known family history of movement disorders or Huntington's chorea. Although the antipsychotic medication had been stopped after development of the
